{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:02:35Z","timestamp":1785333755012,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031977","name":"College of Pharmacy and Pharmaceutical Sciences, Washington State University","doi-asserted-by":"publisher","award":["25CDA1454126"],"award-info":[{"award-number":["25CDA1454126"]}],"id":[{"id":"10.13039\/100031977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151472"],"award-info":[{"award-number":["R01HL151472"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.taap.2025.117600","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:50:57Z","timestamp":1760500257000},"page":"117600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pediatric doxorubicin exposure induces persistent pathological changes in mice"],"prefix":"10.1016","volume":"505","author":[{"given":"Jingrui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahder Dawit","family":"Belew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117600_bb0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117600_bb0010","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1200\/JCO.2017.76.3920","article-title":"Cardiovascular disease in survivors of childhood Cancer: insights into epidemiology, pathophysiology, and prevention","volume":"36","author":"Armenian","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117600_bb0015","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging","volume":"30","author":"Armstrong","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117600_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2006.03.027","article-title":"Adriamycin promotes macrophage dysfunction in mice","volume":"41","author":"Asmis","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2025.117600_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.bjc.6690019","article-title":"Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein","volume":"79","author":"van Asperen","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2025.117600_bb0030","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2352-4642(22)00239-5","article-title":"Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the international late effects of childhood Cancer guideline harmonization group","volume":"6","author":"de Baat","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.taap.2025.117600_bb0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmed.2024.09.004","article-title":"Emerging roles of cyclin-dependent kinase 7 in health and diseases","volume":"31","author":"Belew","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.taap.2025.117600_bb0040","first-page":"383","article-title":"Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma","volume":"8","author":"Bramwell","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2025.117600_bb0045","first-page":"311","article-title":"Body mass index and annual increase of body mass index in long-term childhood cancer survivors; relationship to treatment","volume":"20","author":"Brouwer","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.taap.2025.117600_bb0050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/cvr\/cvae084","article-title":"Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy","volume":"120","author":"Chen","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2025.117600_bb0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/pbc.25369","article-title":"Myocardial iron load and fibrosis in long term survivors of childhood leukemia","volume":"62","author":"Cheung","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.taap.2025.117600_bb0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jpeds.2006.11.036","article-title":"Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study","volume":"150","author":"Chow","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.taap.2025.117600_bb0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2025.117600_bb0070","series-title":"The Mouse in Biomedical Research (2nd edition)","first-page":"637","article-title":"Mouse models in aging research","author":"Flurkey","year":"2007"},{"key":"10.1016\/j.taap.2025.117600_bb0075","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1200\/JCO.2008.16.3527","article-title":"Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood Cancer survivor study","volume":"26","author":"Garmey","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117600_bb0080","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1210\/jc.2003-030784","article-title":"Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study","volume":"88","author":"Gurney","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2025.117600_bb0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00280-001-0392-4","article-title":"Peak plasma concentrations of doxorubicin in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma","volume":"49","author":"Hempel","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2025.117600_bb0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCULATIONAHA.109.902221","article-title":"Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice","volume":"121","author":"Huang","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2025.117600_bb0095","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1210\/jc.2019-00834","article-title":"Hypothalamic-pituitary disorders in childhood Cancer survivors: prevalence, risk factors and long-term health outcomes","volume":"104","author":"van Iersel","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2025.117600_bb0100","doi-asserted-by":"crossref","first-page":"H1091","DOI":"10.1152\/ajpheart.00290.2018","article-title":"Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium","volume":"315","author":"Jadapalli","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2025.117600_bb0105","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/annonc\/mds580","article-title":"Final height in survivors of childhood cancer compared with height standard deviation scores at diagnosis","volume":"24","author":"Knijnenburg","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2025.117600_bb0110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.taap.2025.117600_bb0115","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","article-title":"Doxorubicin blocks cardiomyocyte Autophagic flux by inhibiting lysosome acidification","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2025.117600_bb0120","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia","volume":"23","author":"Lipshultz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117600_bb0125","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2025.117600_bb0130","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/cvr\/cvy064","article-title":"Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes","volume":"114","author":"Matsumura","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2025.117600_bb0135","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/cncr.20960","article-title":"Body mass index in long-term adult survivors of childhood cancer: a report of the childhood Cancer survivor study","volume":"103","author":"Meacham","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2025.117600_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood Cancer survivor study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.taap.2025.117600_bb0145","article-title":"Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the childhood Cancer survivor study cohort","volume":"368","author":"Mulrooney","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.taap.2025.117600_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.taap.2025.117600_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117599","article-title":"New molecular and biochemical insights of doxorubicin-induced hepatotoxicity","volume":"250","author":"Prasanna","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2025.117600_bb0160","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1200\/JCO.19.02892","article-title":"Impact of intrathecal triple therapy versus intrathecal methotrexate on disease-free survival for high-risk B-lymphoblastic leukemia: children\u2019s oncology group study AALL1131","volume":"38","author":"Salzer","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117600_bb0165","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2025.117600_bb0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/CIRCULATIONAHA.107.710434","article-title":"Apoptosis signal-regulating kinase 1\/p38 signaling pathway negatively regulates physiological hypertrophy","volume":"117","author":"Taniike","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2025.117600_bb0175","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jnci\/djae135","article-title":"Prevalence of cancer survivors in the United States","volume":"116","author":"Tonorezos","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.taap.2025.117600_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31080","article-title":"Risk of increased mortality in underweight survivors: a brief report from the childhood Cancer survivor study","volume":"71","author":"Tonorezos","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.taap.2025.117600_bb0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40262-016-0451-y","article-title":"Towards a model-based dose recommendation for doxorubicin in children","volume":"56","author":"Voller","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2025.117600_bb0190","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-specific cardiovascular risks of Cancer and its therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2025.117600_bb0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003088-200746040-00005","article-title":"Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin\u2019s lymphoma and its effect on myelotoxicity","volume":"46","author":"Wilde","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2025.117600_bb0200","doi-asserted-by":"crossref","first-page":"19672","DOI":"10.1074\/jbc.RA118.004673","article-title":"Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy","volume":"293","author":"Xia","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2025.117600_bb0205","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1074\/jbc.RA119.011571","article-title":"Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1","volume":"295","author":"Xia","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2025.117600_bb0210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaccao.2022.10.017","article-title":"RBL2 regulates cardiac sensitivity to anthracycline chemotherapy","volume":"5","author":"Xia","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.taap.2025.117600_bb0215","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/jat.4666","article-title":"Possible pathogenic mechanisms for doxorubicin-induced splenic atrophy in a human breast cancer xenograft mouse model","volume":"44","author":"Xue","year":"2024","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.taap.2025.117600_bb0220","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1203\/PDR.0b013e318184d732","article-title":"A mouse model for juvenile doxorubicin-induced cardiac dysfunction","volume":"64","author":"Zhu","year":"2008","journal-title":"Pediatr. Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2500376X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2500376X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:08:43Z","timestamp":1780722523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2500376X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S0041008X2500376X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117600","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric doxorubicin exposure induces persistent pathological changes in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117600"}}